edaravone has been researched along with Ventricular Dysfunction, Left in 2 studies
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone treatment shifted the %FAC(initial)–%FAC(final) relationship downward (P < 0." | 5.35 | Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats. ( Imai, K; Kawamoto, T; Miyamoto, Y; Neishi, Y; Okura, H; Toyota, E; Yoshida, K, 2009) |
| "Edaravone treatment shifted the %FAC(initial)–%FAC(final) relationship downward (P < 0." | 1.35 | Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats. ( Imai, K; Kawamoto, T; Miyamoto, Y; Neishi, Y; Okura, H; Toyota, E; Yoshida, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyota, E | 1 |
| Miyamoto, Y | 1 |
| Imai, K | 1 |
| Neishi, Y | 1 |
| Kawamoto, T | 1 |
| Okura, H | 1 |
| Yoshida, K | 1 |
| Shimazaki, H | 1 |
| Watanabe, K | 1 |
| Veeraveedu, PT | 1 |
| Harima, M | 1 |
| Thandavarayan, RA | 1 |
| Arozal, W | 1 |
| Tachikawa, H | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
2 other studies available for edaravone and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats.
Topics: Animals; Antipyrine; Consciousness; Disease Models, Animal; Edaravone; Free Radical Scavengers; Hype | 2009 |
The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis.
Topics: Animals; Antioxidants; Antipyrine; Apoptosis; Autoimmune Diseases; Disease Models, Animal; Down-Regu | 2010 |